Story
CBRE Group Sees Surge in Bearish Options Activity Targeting October Expiry

Summary
Options traders placed a significant bearish bet on CBRE Group, with a massive volume of put contracts targeting a near-term drop below the $135 strike price ahead of the October 16 expiration.
A notable surge in bearish options activity was observed in CBRE Group Inc. (NYSE: CBRE) on Wednesday, with put volume far outpacing call volume as the stock declined. The trading suggests a large, directional bet on further downside for the commercial real estate services firm in the coming weeks.
Details of the Trade
The options market for CBRE showed a distinct bearish tilt, with 4,319 put contracts traded against a much smaller number of calls, resulting in a put/call ratio of approximately 10.9-to-1, according to market data. The total put volume marked the highest level seen since February 12, 2026.
The activity was heavily concentrated on a single strike:
- Strike Price: $135 Put
- Expiration Date: October 16, 2026
- Volume: 4,119 contracts
- Prior Open Interest: 229 contracts
The volume on this specific contract was roughly 18 times the existing open interest, indicating that the vast majority of the trades were new positions being established rather than existing ones being closed or rolled.
Market Implications
AdWith CBRE's stock trading around $136.71 at the time of the activity, the $135 strike is nearly at-the-money. This type of trade, combined with the short time to expiry of about 23 days, suggests the trader or traders involved anticipate a swift move below the $135 level before mid-October.
This bearish sentiment comes as the stock has already been under pressure, falling over 10% in the past month. The $135 level sits just above the stock's 52-week low of $121.69, which was hit in June 2026. While overall implied volatility rose, signaling increased uncertainty, the relative cost of puts fell slightly, suggesting the large buyer may have secured an efficient entry for the position.
Context and Background
The options activity adds a layer of bearish sentiment to a mixed fundamental picture for CBRE. The company reported strong second-quarter 2026 results, with core earnings per share up 30% year-over-year, yet the stock sold off following the announcement in a "sell the news" reaction.
Concerns about AI disintermediating the commercial real estate services sector, which pressured the stock in February, have not fully subsided. While some analysts, such as Morgan Stanley, maintain an Overweight rating with a $180 price target, the market's current momentum appears to be siding with the bears. A stock sale by the company's CFO at $130.74 in May 2026 also adds to the complex insider sentiment picture.
Read next
More on Stocks
Peloton Reportedly Explores $800 Million Debut Bond Sale
Peloton Interactive is considering its first-ever bond offering to raise $800 million, according to a Bloomberg report citing people familiar with the matter. The news sent the company's shares down over 4% in Wednesday trading.

1789 Capital Seeks $3 Billion for Second Growth Fund, Bloomberg Reports
The investment firm, where Donald Trump Jr. is a partner, has reportedly secured $2 billion toward its target for a new fund focused on larger investments in sectors like AI and defense.

Arcturus Stock Gains on Positive Drug Trial Data and New mRNA Platform
Arcturus Therapeutics shares rose after the company released encouraging interim Phase 2 data for its OTC deficiency treatment and unveiled a next-generation mRNA delivery platform with significantly higher potency.

Gossamer Bio Shares Climb After Filing First-Ever FDA Drug Application for Seralutinib
The clinical-stage biopharmaceutical company has submitted a New Drug Application for its pulmonary arterial hypertension treatment, seralutinib, prompting a rise in its stock during after-hours trading.